| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003458348 |
| P356 | DOI | 10.1007/S00213-015-3956-4 |
| P698 | PubMed publication ID | 25971875 |
| P50 | author | Marco Pereira | Q42225620 |
| Renata Fialho | Q63662510 | ||
| P2093 | author name string | Jeremy Tibble | |
| Richard Whale | |||
| Majella Keller | |||
| Alexandra File | |||
| Alison Burridge | |||
| P2860 | cites work | Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 |
| Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis | Q26822903 | ||
| Antidepressant-induced liver injury: a review for clinicians | Q28304529 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 | ||
| Mechanism of action of interferon and ribavirin in treatment of hepatitis C | Q29619805 | ||
| Interferon-alpha Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment | Q33750627 | ||
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 | ||
| Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity | Q33948018 | ||
| Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients | Q34124551 | ||
| A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia | Q34247698 | ||
| Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review | Q34313334 | ||
| Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis | Q34394602 | ||
| IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. | Q34599798 | ||
| Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis | Q34642429 | ||
| The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis | Q35356649 | ||
| Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection | Q35903305 | ||
| Innate immunity in the liver | Q36036373 | ||
| Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior | Q36111806 | ||
| Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. | Q36539999 | ||
| Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study. | Q37136152 | ||
| Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus | Q37943532 | ||
| Serotonin: a double-edged sword for the liver? | Q37961304 | ||
| New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. | Q37978196 | ||
| Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis | Q38135107 | ||
| The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters | Q40321786 | ||
| Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression? | Q43037678 | ||
| A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. | Q44194141 | ||
| Aggravation of viral hepatitis by platelet-derived serotonin | Q45218233 | ||
| Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-kappaB inactivation | Q45422690 | ||
| Pre-treatment waking cortisol response and vulnerability to interferon α induced depression | Q48522872 | ||
| Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response | Q48581559 | ||
| 5-HT(1A) receptor and apoptosis contribute to interferon-α-induced "depressive-like" behavior in mice | Q48714540 | ||
| Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs | Q60683342 | ||
| P433 | issue | 9 | |
| P921 | main subject | norepinephrine | Q186242 |
| P304 | page(s) | 1689-1694 | |
| P577 | publication date | 2015-05-15 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C | |
| P478 | volume | 233 |
| Q50534307 | Immune influences on the brain: new findings and implications for treatment. | cites work | P2860 |
Search more.